Keywords
associated factors
sickle cell disease
Kinshasa
How to Cite
Abstract
Introduction
Sickle cell disease is the most common genetic disorder worldwide, primarily affecting individuals of African, Mediterranean, and Asian descent. Previous studies have reported that patients with sickle cell disease are predisposed to tonsillar hypertrophy as a result of compensatory immune responses to functional asplenia and recurrent infections.
Purpose
The main objective of this study was to determine the frequency of tonsillar hypertrophy in sickle cell patients followed at our centre and to identify the associated risk factors.
Methods
This was a cross-sectional analytical study conducted at the Centre for Mixed Medicine and Sickle Cell Anaemia (CMMASS), Kinshasa, from September 2022 to February 2023. The sample comprised homozygous SS sickle cell patients aged six years and above who were followed up at CMMASS. The size of the palatine tonsils was assessed according to Friedman’s criteria. Data were analysed using IBM Statistical Package for the Social Sciences (SPSS) version 26.0. Associations between variables were tested using the chi-square test, with statistical significance set at p < 0.05.
Results
A total of 123 patients with sickle cell disease participated in the study, with a median age of 15 years (range: 6–50 years). Females accounted for 58.5% of participants. The prevalence of tonsillar hypertrophy was 57.7%. Treatment without hydroxyurea (adjusted OR = 10.53 [1.74–63.59]; p = 0.010), presence of jaundice (adjusted OR = 4.21 [1.33–13.39]; p = 0.015), and haemoglobin ≤ 7.9 g/dL (adjusted OR = 7.55 [2.85–19.99]; p = 0.001) were identified as factors significantly associated with tonsillar hypertrophy among sickle cell patients.
Conclusions
Tonsillar hypertrophy is common among sickle cell patients in our setting. Addressing the associated risk factors identified in this study could help reduce its frequency.
References
Abou-Elhamd, K. A. (2011). Otorhinolaryngological manifestations of sickle cell disease. International Journal of Pediatric Otorhinolaryngology, 76(1), 1–4. https://doi.org/10.1016/j.ijporl.2011.10.004
Adekanye, A., Akaba, K., Umana, A., Mgbe, R., Francis, P., & Okoi-Obuli, J. (2023). Demographics of tonsillar hypertrophy among sickle cell disease patients in Calabar. Nigerian Journal of Clinical Practice, 26(7), 1023–1028. https://doi.org/10.4103/njcp.njcp_59_23
Brandow, A. M., & Liem, R. I. (2022a). Advances in the diagnosis and treatment of sickle cell disease. Journal of Hematology & Oncology, 15(1), Article 45. https://doi.org/10.1186/s13045-022-01237-z
Brandow, A. M., & Liem, R. I. (2022b). Advances in the diagnosis and treatment of sickle cell disease. Journal of Hematology & Oncology, 15(1), Article 45. https://doi.org/10.1186/s13045-022-01237-z
Dzon, H. B. O., Ngouoni, G. C., Diembi, S., Odzili, F. A. I., Kambourou, J., Tsierie-Tsoba, A., … Ondzotto, G. (2019). Amygdalectomy in children with homozygotic drepanocytosis at the University Teaching Hospital in Brazzaville. [Unpublished manuscript]. Google Scholar.
Elendu, C., Amaechi, D. C., Alakwe-Ojimba, C. E., Elendu, T. C., Elendu, R. C., Ayabazu, C. P., Aina, T. O., Aborisade, O., & Adenikinju, J. S. (2023). Understanding sickle cell disease: Causes, symptoms, and treatment options. Medicine, 102(38), e35237. https://doi.org/10.1097/md.0000000000035237
François, M. (2009). L’hypertrophie bilatérale des amygdales palatines. Journal de Pédiatrie et de Puériculture, 22(1), 29–32. https://doi.org/10.1016/j.jpp.2008.12.002
Friedman, M., Salapatas, A. M., & Bonzelaar, L. B. (2017). Updated Friedman staging system for obstructive sleep apnea. Advances in Oto-Rhino-Laryngology, 80, 41–48. https://doi.org/10.1159/000470859
Góis, C., D’Ávila, J., Cipolotti, R., Lira, A., & Silva, A. (2017). Adenotonsillar hypertrophy in pre-school children with sickle cell disease and diagnostic accuracy of the Sleep Disturbance Scale for Children. International Archives of Otorhinolaryngology, 22(1), 55–59. https://doi.org/10.1055/s-0037-1602702
Mario, N., & Sala, N. (2016). Diagnostic biologique des hémoglobinopathies. Revue Francophone des Laboratoires, 481, 35–47. [Unpublished manuscript]. Google Scholar.
Meier, E. R. (2018). Treatment options for sickle cell disease. Pediatric Clinics of North America, 65(3), 427–443. https://doi.org/10.1016/j.pcl.2018.01.005
Opoku-Buabeng, J., & Akoto, A. (2012). Hypertrophic tonsils in sickle cell patients in Ghana. Journal of the West African College of Surgeons, 2(3), 1–11. PubMed.
Pace, B. S., Starlard-Davenport, A., & Kutlar, A. (2021). Sickle cell disease: Progress towards combination drug therapy. British Journal of Haematology, 194(2), 240–251. https://doi.org/10.1111/bjh.17312
Piel, F. B., Howes, R. E., Patil, A. P., Nyangiri, O. A., Gething, P. W., Bhatt, S., Williams, T. N., Weatherall, D. J., & Hay, S. I. (2013). The distribution of haemoglobin C and its prevalence in newborns in Africa. Scientific Reports, 3(1), Article 1671. https://doi.org/10.1038/srep01671
Powell, S., Kubba, H., O’Brien, C., & Tremlett, M. (2010). Paediatric obstructive sleep apnoea. BMJ, 340, c1918. https://doi.org/10.1136/bmj.c1918
Salles, C., Ramos, R. T. T., Daltro, C., Nascimento, V. M., & Matos, M. A. (2009). Association between adenotonsillar hypertrophy, tonsillitis, and painful crises in sickle cell disease. Jornal de Pediatria, 85(3), 249–253. https://doi.org/10.2223/jped.1898
Stuart, A., & Smith, M. R. (2019). The emergence and prevalence of hearing loss in children with homozygous sickle cell disease. International Journal of Pediatric Otorhinolaryngology, 123, 69–74. https://doi.org/10.1016/j.ijporl.2019.04.032
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2018). Pathophysiology of sickle cell disease. Annual Review of Pathology: Mechanisms of Disease, 14(1), 263–292. https://doi.org/10.1146/annurev-pathmechdis-012418-012838
Wali, Y., Al-Lamki, Z., Soliman, H., & Al-Okbi, H. (2000). Adenotonsillar hypertrophy: A precipitating factor of cerebrovascular accident in a child with sickle cell anaemia. Journal of Tropical Pediatrics, 46(4), 246–248. https://doi.org/10.1093/tropej/46.4.246
Yalombe, H. N., Kalala, H. K., Mpiana, S. J., Yambayamba, M. K., Lobukulu, G. L., & Nyembue, D. T. (2025). Frequency and risk factors associated with hearing loss in sickle cell patients at the SS Mixed Medicine and Anemia Center in Kinshasa: A cross-sectional study. Annales Africaines de Médecine, 18(2), e5977–e5985. Google Scholar. https://dx.doi.org/10.4314/aamed.v18i2.8
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.